Sumitomo Mitsui Trust Group, Inc. 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-27 06:57 am Sale | 2025-09-30 | 13G | 10x Genomics, Inc. TXG | Sumitomo Mitsui Trust Group, Inc. | 5,381,219 4.700% | -632,770 (-10.52%) | Filing |
| 2025-07-31 06:07 am Purchase | 2025-06-30 | 13G | 10x Genomics, Inc. TXG | Sumitomo Mitsui Trust Group, Inc. | 6,013,989 5.400% | 650,623 (+12.13%) | Filing |
| 2025-04-25 06:22 am Sale | 2025-03-31 | 13G | 10x Genomics, Inc. TXG | Sumitomo Mitsui Trust Group, Inc. | 5,363,366 5.000% | -1,009,846 (-15.85%) | Filing |
| 2024-11-05 06:07 am Purchase | 2024-09-30 | 13G | 10x Genomics, Inc. TXG | Sumitomo Mitsui Trust Group, Inc. | 6,373,212 5.980% | 6,373,212 (New Position) | Filing |